| PATENT ASSIGNEE'S COUNTRY | USA |
| UPDATE | 05.00 |
| PATENT NUMBER | This data is not available for free |
| PATENT GRANT DATE | 02.05.00 |
| PATENT TITLE |
Tie ligand homologues |
| PATENT ABSTRACT |
The present invention concerns isolated nucleic acid molecules encoding the novel TIE ligands NL1, NL5, NL8, and NL4, the proteins encoded by such nucleic acid molecules, as well as methods and means for making and using such nucleic acid and protein molecules. |
| PATENT INVENTORS | This data is not available for free |
| PATENT ASSIGNEE | This data is not available for free |
| PATENT FILE DATE | 29.10.97 |
| PATENT REFERENCES CITED |
GenBank Accession No. T11442, CHR900008 Homo sapiens genomic clone 14C-1 5' and 3' similar to fibrinogen-like domain, accessed Jan. 7, 1999, Nov. 1993. Davis et al. Cell 87:1161-1169 (1996). Dumont et al. Oncogene 8:1293-1301 (1993). Kaipainen et al. Cander Res. 54:6571-6577 (1994). Korhonen et al. Blood 80:2548-2555 (1992). Maisonpierre et al. Oncogene 8:1631-1637 (1993). Partanen et al., "Putative Tyrosine Kinases Expressed in K-562 Human Leukemia Cells" Proc. Natl. Acad. Sci. 87:8913-8917 (1990). Suri et al. Cell 87:1171-1180 (1996). Hanahan, D., Signaling vascular morphogenesis and maintenance, Science, 277: 48-50, Jul. 1997. |
| PATENT PARENT CASE TEXT | This data is not available for free |
| PATENT CLAIMS |
We claim: 1. An isolated nucleic acid molecule hybridizing to the complement of the nucleic acid of SEQ ID NO: 1 under the following conditions: incubation in a mixture of 5 .times.SSPE, 2.times.Denhardt's solution, 100 mg/ml denatured sheared salmon sperm DNA, 50% formamide, and 2% SDS at 42.degree. C., followed by washed in a mixture of 2.times.SSC, and 0.05% SDS at room temperature and 0.1.times.SSC and 0.1% SDS at 50.degree. C., wherein said nucleic acid molecule encodes a polypeptide that binds to a native TIE receptor. 2. The isolated nucleic acid molecule of claim 1 which comprises the coding region of SEQ. ID. NO: 1. 3. The isolated nucleic acid molecule of claim 1 which comprises the coding sequence of amino acid positions 270 to 493 of SEQ ID NO: 2. 4. A vector which comprises a nucleic acid molecule of claim 1. 5. A recombinant host cell transformed with a nucleic acid molecule according to claim 1. 6. The recombinant host cell of claim 5 which is a prokaryotic cell. 7. The recombinant host cell of claim 5 which is a eukaryotic cell. 8. A vector which comprises the nucleic acid molecule of claim 2. 9. A recombinant host cell transformed with the nucleic acid molecule of claim 2. 10. The recombinant host cell of claim 9 which is a prokaryotic cell. 11. The recombinant host cell of claim 9 which is a eukaryotic cell. 12. A vector which comprises the nucleic acid molecule of claim 3. 13. A recombinant host cell transformed with the nucleic acid molecule of claim 3. 14. The recombinant host cell of claim 13 which is a prokaryotic cell. 15. The recombinant host cell of claim 13 which is a eukaryotic cell. 16. An isolated nucleic acid molecule comprising a nucleic acid encoding an NL1 polypeptide having the sequence of SEQ ID NO: 2. 17. A vector which comprises the nucleic acid molecule of claim 16. 18. A recombinant host cell transformed with the nucleic acid molecule of claim 16. 19. An isolated nucleic acid molecule comprising a nucleic acid encoding a polypeptide having the sequence of amino acids 270 to 493 of SEQ ID NO: 2. 20. A vector which comprises the nucleic acid molecule of claim 19. 21. A recombinant host cell transformed with the nucleic acid molecule of claim 19. |
| PATENT PHOTOCOPY | Available on request |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |